Developer docs
API playgroundTry for free, no card

Search company profiles

Faba

Full company profile

uuid0004jgz

Namestring
Faba
Legal namestring
FABA CAPITAL a.s.
Websiteurl
fabacapital.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

FABA CAPITAL a.s. (operating as Faba Capital) is a privately held venture capital and investment firm incorporated in the Czech Republic (headquartered at Varišavská 715/36, Praha 2; IČO 099 49 411). The firm invests in and operates a portfolio of companies in the Central and Eastern European region across healthcare, biotechnology, medical technology, assisted reproduction, nuclear energy, senior services, and digital health. Its portfolio/wholly-owned subsidiaries include Medical Meadow a.s. (premium medical care: surgery, dentistry, gynecology, general practice, assisted reproduction), FABA INCUBE a.s. (a Prague-based startup incubator bridging university research and industry, launched 4 May 2023), AGORA Pharmaceuticals s.r.o. (Alzheimer's-focused biotech, founded 2015), Fetus, IVF a.s. (assisted reproduction with patent-pending miRNA diagnostic/embryo-selection technology, acquired 31 January 2023), Grandsenior s.r.o. (online senior-care marketplace), and Teledoc/JSM Teledoc (online medical/therapeutic platform). The firm additionally holds a strategic position in the NAPOLEON HR-4F nuclear hydrogen project.

The investment approach is built around a stated CSR/ESG methodology for portfolio construction and a stated preference for innovative CEE projects with global ambition and positive societal impact. The firm does not publicly disclose pricing, AUM, or revenue. Its disclosed capital instruments include a $1.2M funding round dated 31 January 2019 (investor: C.C.T Consulting), and two corporate bond programs issued in late 2024 — FABA CAPITAL 12,25/28 (November 2024) and FABA CAPITAL 14,25/28 (December 2024) — each with published emission terms, guarantor declarations, and a December 2024 amendment supplement. Revenue mechanics therefore combine (i) equity returns and operating income from subsidiaries, (ii) bond-funded capital operations, and (iii) selective direct investment in early-stage projects.

The firm is led by CEO and founder Robert Flocius, with Roman Valovič as Marketing Director and Petr Čihák as CEO of FABA INCUBE. Go-to-market is primarily direct outreach to CEE startups, supported by Czech/Slovak-language content marketing (blog) and press releases tied to portfolio milestones. The customer base is dual-sided: portfolio-company investees on one side, and the end-user customer bases of the operating subsidiaries (medical patients, IVF patients, seniors, telehealth users) on the other. The firm operates from a single headquarters in Prague with no disclosed additional offices despite the "UK" country tag in third-party firmographic data, which conflicts with the primary-source Czech HQ.

Short descriptiontext

FABA CAPITAL a.s. is a private Czech venture capital and investment firm that builds and backs a portfolio of innovative healthcare, biotech, nuclear-energy and senior-services companies across Central and Eastern Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPrague, Czechia
HQ citystring
Prague
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, startup incubation services, portfolio company management, biotech investment funding, CEE innovation financing
Industry2 codes
PRIMARYFSANAHAG
Corporate M&A / Venture Build-to-Buy Programs (Acqui-hire, option-to-acquire)
SECONDARYBPAHAOAL
Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory)
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • All Other Financial Investment Activities52399
SIC code2 codes
  • Investors, Nec6799
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Venture Capital and Private Equity
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1NAPOLEON HR-4F
Description

Nuclear reactor concept - gas-cooled fast reactor IV generation focused on hydrogen production led by CEO Branislav Hatala

fabacapital.com
+6 more records
Core offering1 text field

Faba Capital is a privately held venture capital and investment firm that invests in and supports innovative projects in the Central and Eastern European (CEE) region. The firm raises capital through bond emissions and direct investor outreach, then deploys it into a multi-sector portfolio spanning healthcare, biotechnology, assisted reproduction, nuclear energy, medical services, senior care, and startup incubation, providing portfolio companies with capital, due diligence, and strategic partnership support under CSR and ESG principles.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

FABA Capital is a venture capital investment firm that provides investment services to innovative projects in the Central and Eastern European (CEE) region with global ambitions. The company operates as a multi-project portfolio platform, supporting companies across healthcare sectors including biotech/pharmaceuticals (AGORA Pharmaceuticals), medical services (Medical Meadow, Teledoc), assisted reproduction (Fetus IVF), and deep tech (NAPOLEON HR-4F nuclear reactors). Additionally, FABA operates FABA INCUBE, a startup incubator for universities and research institutions, and maintains a marketplace for seniors (Grandsenior). The investment approach emphasizes CSR and ESG strategies with positive societal impact.

Product and service8 records
1FABA Capital Venture Capital Investment
CategoryVenture Capital Investment
2Medical Meadow Premium Medical Care
CategoryHealthcare Services
3FABA INCUBE Startup Incubation
CategoryStartup Incubation
4Fetus, IVF Assisted Reproduction Services
CategoryAssisted Reproduction / Medical Services
5AGORA Pharmaceuticals Drug Development
CategoryBiotechnology / Pharmaceuticals
6NAPOLEON HR-4F Nuclear Reactor Concept
CategoryDeep Tech / Nuclear Energy
7Teledoc Telehealth Platform
CategoryTelehealth Platform
8Grandsenior Senior Marketplace
CategorySenior Care Marketplace
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nuclear technology company developing a new concept of gas-cooled fast reactor IV generation. Main goal is hydrogen production. Led by CEO Branislav Hatala with extensive experience in nuclear safety.

2AGORA Pharmaceuticals s.r.o.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biotechnology company founded in 2015 focused on developing new advanced drugs for neurodegenerative diseases, especially Alzheimer's disease.

fabacapital.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Platform enabling communication between doctors, therapists, volunteers, and those who need help. Addresses problems with doctor shortages and growing mental health issues.

4Grandsenior s.r.o.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Online marketplace cooperating with retirement homes, helping elderly people access products and services for quality living including healthy food, hygiene products, medical supplies, and travel.

fabacapital.com
5Medical Meadow a.s.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Medical division of FABA CAPITAL providing premium medical care in surgery, dentistry, general practice, gynecology, and assisted reproduction.

fabacapital.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Startup incubator helping universities and research institutions apply primary research to industry or business, focusing on innovative ideas, patents, and projects from European grant programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Assisted reproduction company with patented miRNA technology for predicting women's readiness for IVF and selecting suitable embryos to increase IVF success rates.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Prague-headquartered venture capital firm investing in ambitious CEE founders across Central Europe. Highly comparable as a CEE-focused, regionally-rooted VC competing for the same deal flow and limited partner base as Faba Capital.

TypeDirect peer
Description

Czech Republic-based VC firm investing across CEE into early-stage startups. Comparable in geography, fund size, and stage focus, and a direct competitor for the same regional portfolio opportunities Faba targets.

TypeDirect peer
Description

CEE-focused early-stage venture capital investor with offices in Budapest and presence across the region. Directly comparable on regional focus, stage, and target portfolio company profile to Faba's venture activities.

TypeDirect peer
Description

Czech investment group operating across multiple verticals with both venture and operating company involvement. Comparable to Faba in its hybrid holding-company + investor model and Central European base.

TypeEmerging player
Description

Tokenized venture capital fund that issues security tokens to provide liquid, fractional access to VC exposure. Comparable to Faba specifically through the token/innovative-VC-market positioning described in the company's short description.

TypeBroad incumbent
Description

One of Europe's longest-standing venture capital firms with broad sector coverage across technology and digital health. Comparable as a larger incumbent operating in the same general European VC market Faba is addressing.

TypeBroad incumbent
Description

European venture capital firm with multiple sector-focused funds, including deep tech and health. Comparable to Faba as a broader European VC incumbent operating at much larger AUM in partially overlapping categories like healthtech and frontier tech.

8Atomico
TypeBroad incumbent
Description

European technology venture capital firm founded by Skype co-founder, investing across stages and geographies in Europe. Comparable as a much larger European VC incumbent whose portfolio includes deep tech and healthcare adjacencies that overlap with Faba's verticals.

TypeBroad incumbent
Description

Global venture capital firm investing across stages in technology and life sciences. Comparable as an established global VC incumbent whose life sciences and frontier-tech funds overlap with Faba's biotech (AGORA) and deep tech (NAPOLEON HR-4F) bets.

TypeOthers
Description

Tokenized investment and private-markets platform enabling broader access to venture and private deals. Comparable to Faba specifically through the token-based access-to-private-markets value proposition highlighted in Faba's "Innovative Token" positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Faba

Venture Capital and Private Equityfabacapital.com

FABA CAPITAL a.s. is a private Czech venture capital and investment firm that builds and backs a portfolio of innovative healthcare, biotech, nuclear-energy and senior-services companies across Central and Eastern Europe.

What Faba does

FABA CAPITAL a.s. (operating as Faba Capital) is a privately held venture capital and investment firm incorporated in the Czech Republic (headquartered at Varišavská 715/36, Praha 2; IČO 099 49 411). The firm invests in and operates a portfolio of companies in the Central and Eastern European region across healthcare, biotechnology, medical technology, assisted reproduction, nuclear energy, senior services, and digital health. Its portfolio/wholly-owned subsidiaries include Medical Meadow a.s. (premium medical care: surgery, dentistry, gynecology, general practice, assisted reproduction), FABA INCUBE a.s. (a Prague-based startup incubator bridging university research and industry, launched 4 May 2023), AGORA Pharmaceuticals s.r.o. (Alzheimer's-focused biotech, founded 2015), Fetus, IVF a.s. (assisted reproduction with patent-pending miRNA diagnostic/embryo-selection technology, acquired 31 January 2023), Grandsenior s.r.o. (online senior-care marketplace), and Teledoc/JSM Teledoc (online medical/therapeutic platform). The firm additionally holds a strategic position in the NAPOLEON HR-4F nuclear hydrogen project.

The investment approach is built around a stated CSR/ESG methodology for portfolio construction and a stated preference for innovative CEE projects with global ambition and positive societal impact. The firm does not publicly disclose pricing, AUM, or revenue. Its disclosed capital instruments include a $1.2M funding round dated 31 January 2019 (investor: C.C.T Consulting), and two corporate bond programs issued in late 2024 — FABA CAPITAL 12,25/28 (November 2024) and FABA CAPITAL 14,25/28 (December 2024) — each with published emission terms, guarantor declarations, and a December 2024 amendment supplement. Revenue mechanics therefore combine (i) equity returns and operating income from subsidiaries, (ii) bond-funded capital operations, and (iii) selective direct investment in early-stage projects.

The firm is led by CEO and founder Robert Flocius, with Roman Valovič as Marketing Director and Petr Čihák as CEO of FABA INCUBE. Go-to-market is primarily direct outreach to CEE startups, supported by Czech/Slovak-language content marketing (blog) and press releases tied to portfolio milestones. The customer base is dual-sided: portfolio-company investees on one side, and the end-user customer bases of the operating subsidiaries (medical patients, IVF patients, seniors, telehealth users) on the other. The firm operates from a single headquarters in Prague with no disclosed additional offices despite the "UK" country tag in third-party firmographic data, which conflicts with the primary-source Czech HQ.

Faba firmographics

Firmographics
Name
Faba
Legal name
FABA CAPITAL a.s.
Website
https://fabacapital.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
FABA CAPITAL a.s. is a private Czech venture capital and investment firm that builds and backs a portfolio of innovative healthcare, biotech, nuclear-energy and senior-services companies across Central and Eastern Europe.
Ownership category
akta.pro rank

Faba industry classification

Industry
Product category
Venture Capital and Private Equity
NAICS
Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)
SIC
Investors, Nec (6799), Security Brokers, Dealers & Flotation Companies (6211)
akta.pro industry
PRIMARYFSANAHAG
Corporate M&A / Venture Build-to-Buy Programs (Acqui-hire, option-to-acquire)
SECONDARYBPAHAOAL
Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory)

Keywords

  • Venture capital investing
  • Startup incubation services
  • Portfolio company management
  • Biotech investment funding
  • CEE innovation financing

Where Faba is headquartered

Location

Headquarters

HQ city
Prague
HQ country
Czechia
HQ region
Europe

Offices1 record

Markets served

Faba business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Distribution channels1 record

Marketing channels3 records

Faba product offering

Product offering

Core offering

Faba Capital is a privately held venture capital and investment firm that invests in and supports innovative projects in the Central and Eastern European (CEE) region. The firm raises capital through bond emissions and direct investor outreach, then deploys it into a multi-sector portfolio spanning healthcare, biotechnology, assisted reproduction, nuclear energy, medical services, senior care, and startup incubation, providing portfolio companies with capital, due diligence, and strategic partnership support under CSR and ESG principles.

Product overview

FABA Capital is a venture capital investment firm that provides investment services to innovative projects in the Central and Eastern European (CEE) region with global ambitions. The company operates as a multi-project portfolio platform, supporting companies across healthcare sectors including biotech/pharmaceuticals (AGORA Pharmaceuticals), medical services (Medical Meadow, Teledoc), assisted reproduction (Fetus IVF), and deep tech (NAPOLEON HR-4F nuclear reactors). Additionally, FABA operates FABA INCUBE, a startup incubator for universities and research institutions, and maintains a marketplace for seniors (Grandsenior). The investment approach emphasizes CSR and ESG strategies with positive societal impact.

Differentiator

Problem solved

Functional benefit

Brands

  • NAPOLEON HR-4F: Nuclear reactor concept - gas-cooled fast reactor IV generation focused on hydrogen production led by CEO Branislav Hatala
  • AGORA Pharmaceuticals
  • Medical Meadow
  • FABA INCUBE
  • Fetus IVF
  • Grandsenior
  • Teledoc

Products and services

  • FABA Capital Venture Capital Investment
  • Medical Meadow Premium Medical Care
  • FABA INCUBE Startup Incubation
  • Fetus, IVF Assisted Reproduction Services
  • AGORA Pharmaceuticals Drug Development
  • NAPOLEON HR-4F Nuclear Reactor Concept
  • Teledoc Telehealth Platform
  • Grandsenior Senior Marketplace

Companies that use Faba

Customer profile

Segments1 record

Ideal customer profiles2 records

Faba technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Faba partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core.

  • Napoleon HR-4FcoreStrategic or Co-development PartnerNuclear technology company developing a new concept of gas-cooled fast reactor IV generation. Main goal is hydrogen production. Led by CEO Branislav Hatala with extensive experience in nuclear safety.
  • AGORA Pharmaceuticals s.r.o.coreStrategic or Co-development PartnerBiotechnology company founded in 2015 focused on developing new advanced drugs for neurodegenerative diseases, especially Alzheimer's disease.
  • Teledoc (Jsme Teledoc)coreStrategic or Co-development PartnerPlatform enabling communication between doctors, therapists, volunteers, and those who need help. Addresses problems with doctor shortages and growing mental health issues.
  • Grandsenior s.r.o.coreStrategic or Co-development PartnerOnline marketplace cooperating with retirement homes, helping elderly people access products and services for quality living including healthy food, hygiene products, medical supplies, and travel.
  • Medical Meadow a.s.coreStrategic or Co-development PartnerMedical division of FABA CAPITAL providing premium medical care in surgery, dentistry, general practice, gynecology, and assisted reproduction.
  • FABA INCUBE a.s.coreStrategic or Co-development PartnerStartup incubator helping universities and research institutions apply primary research to industry or business, focusing on innovative ideas, patents, and projects from European grant programs.
  • Fetus, IVF a.s.coreStrategic or Co-development PartnerAssisted reproduction company with patented miRNA technology for predicting women's readiness for IVF and selecting suitable embryos to increase IVF success rates.

Scale indicators1 record

Recent moves7 records

Expansion highlights5 records

Faba competitors and assessment

Company assessment

Direct peers

  • Credo Ventures: Prague-headquartered venture capital firm investing in ambitious CEE founders across Central Europe. Highly comparable as a CEE-focused, regionally-rooted VC competing for the same deal flow and limited partner base as Faba Capital.
  • Pale Fire Capital: Czech Republic-based VC firm investing across CEE into early-stage startups. Comparable in geography, fund size, and stage focus, and a direct competitor for the same regional portfolio opportunities Faba targets.
  • Day One Capital: CEE-focused early-stage venture capital investor with offices in Budapest and presence across the region. Directly comparable on regional focus, stage, and target portfolio company profile to Faba's venture activities.
  • Rockaway Capital: Czech investment group operating across multiple verticals with both venture and operating company involvement. Comparable to Faba in its hybrid holding-company + investor model and Central European base.

Emerging players

  • SPiCE VC: Tokenized venture capital fund that issues security tokens to provide liquid, fractional access to VC exposure. Comparable to Faba specifically through the token/innovative-VC-market positioning described in the company's short description.

Broad incumbents

  • Earlybird Venture Capital: One of Europe's longest-standing venture capital firms with broad sector coverage across technology and digital health. Comparable as a larger incumbent operating in the same general European VC market Faba is addressing.
  • Speedinvest: European venture capital firm with multiple sector-focused funds, including deep tech and health. Comparable to Faba as a broader European VC incumbent operating at much larger AUM in partially overlapping categories like healthtech and frontier tech.
  • Atomico: European technology venture capital firm founded by Skype co-founder, investing across stages and geographies in Europe. Comparable as a much larger European VC incumbent whose portfolio includes deep tech and healthcare adjacencies that overlap with Faba's verticals.
  • Index Ventures: Global venture capital firm investing across stages in technology and life sciences. Comparable as an established global VC incumbent whose life sciences and frontier-tech funds overlap with Faba's biotech (AGORA) and deep tech (NAPOLEON HR-4F) bets.

Others

  • Republic: Tokenized investment and private-markets platform enabling broader access to venture and private deals. Comparable to Faba specifically through the token-based access-to-private-markets value proposition highlighted in Faba's "Innovative Token" positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

Faba social profiles

Digital presence

Faba financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Faba leadership team

Management profile

Number of profiles

Profiles4 records

Faba subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Faba funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Faba M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Faba

What does Faba do?

Faba Capital is a privately held venture capital and investment firm that invests in and supports innovative projects in the Central and Eastern European (CEE) region. The firm raises capital through bond emissions and direct investor outreach, then deploys it into a multi-sector portfolio spanning healthcare, biotechnology, assisted reproduction, nuclear energy, medical services, senior care, and startup incubation, providing portfolio companies with capital, due diligence, and strategic partnership support under CSR and ESG principles.

Is Faba a public or private company?

Faba is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Faba founded?

Faba was founded in 2018. It employs 1 to 10 people.

Where is Faba based?

Faba is headquartered in Prague, Czechia, in the Europe region.

Who are Faba's main competitors?

Direct peers on record are Credo Ventures, Pale Fire Capital, Day One Capital and Rockaway Capital. SPiCE VC is listed as an emerging player. Broad incumbents are Earlybird Venture Capital, Speedinvest, Atomico and Index Ventures. Republic is listed as an others.

Does Faba have an API?

No public API is recorded for Faba.

What industry is Faba in?

Faba's product category is Venture Capital and Private Equity. Its primary akta.pro industry code is FSANAHAG, Corporate M&A / Venture Build-to-Buy Programs (Acqui-hire, option-to-acquire), with a secondary code of BPAHAOAL, Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory). Its NAICS code is 523940 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals